Current Liabilities
Derivative Liabilities - Fair Value
ResMed Derivative Liabilities - Fair Value increased by 13.6% to $145.39M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 204.2%, from $47.79M to $145.39M. Over 3 years (FY 2022 to FY 2025), Derivative Liabilities - Fair Value shows an upward trend with a 308.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ4 2018
Last reportedQ1 2026
How to read this metric
An increase indicates higher potential cash outflows or increased market exposure to counterparties.
Detailed definition
This represents the total fair value of derivative financial instruments that are in a net liability position at the rep...
Peer comparison
Standard disclosure for all banks with significant trading or derivative portfolios.
Metric ID:
derivative_liabilities_fair_valueHistorical Data
15 periods
| Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.95M | $40.02M | $61.59M | $70.70M | $52.85M | $72.61M | $46.39M | $36.54M | $74.73M | $18.23M | $47.79M | $132.82M | $136.73M | $127.96M | $145.39M |
| QoQ Change | — | >999% | +53.9% | +14.8% | -25.3% | +37.4% | -36.1% | -21.2% | +104.5% | -75.6% | +162.2% | +177.9% | +2.9% | -6.4% | +13.6% |
| YoY Change | — | — | — | >999% | — | +81.4% | -24.7% | -48.3% | +41.4% | -74.9% | +3.0% | +263.5% | +83.0% | +602.0% | +204.2% |
Range$1.95M – $145.39M
CAGR+242.9%
Avg YoY Growth+423.8%
Median YoY Growth+81.4%
Derivative Liabilities - Fair Value at Other Companies
Frequently Asked Questions
- What is ResMed's derivative liabilities - fair value?
- ResMed (RMD) reported derivative liabilities - fair value of $145.39M in Q1 2026.
- How has ResMed's derivative liabilities - fair value changed year-over-year?
- ResMed's derivative liabilities - fair value increased by 204.2% year-over-year, from $47.79M to $145.39M.
- What is the long-term trend for ResMed's derivative liabilities - fair value?
- Over 3 years (2022 to 2025), ResMed's derivative liabilities - fair value has grown at a 308.6% compound annual growth rate (CAGR), from $1.95M to $132.82M.
- What does derivative liabilities - fair value mean?
- The current market value of all derivative contracts where the bank is in a net owing position.